See also this year's filing and all EDGAR filings for this company.
PDF Report 0001590750_2019_Viridian_Therapeutics_Inc_DE.pdf
Logs
Graph
Absolute values for 0001590750, Viridian Therapeutics Inc.\DE
xvar | xval | |
---|---|---|
0 | IntangibleAssets | 0 |
1 | AssetsNonCurrent | 50,000 |
2 | AssetsCurrent | 65,370,000 |
3 | PropertyPlantAndEquipment | 727,000 |
4 | remainder_Assets | 0 |
5 | LongTermLiabilities | 8,070,000 |
6 | LiabilitiesCurrent | 6,733,000 |
7 | remainder_Liabilities | 0 |
8 | LaborExpense | 0 |
9 | CostOfGoodsAndServicesSold | 0 |
10 | GeneralAndAdministrativeExpense | 11,049,000 |
11 | GoodwillImpairmentLoss | 0 |
12 | OperatingCostsAndExpenses | 0 |
13 | DepreciationDepletionAndAmortization | 0 |
14 | SellingAndMarketingExpense | 0 |
15 | ResearchAndDevelopmentExpense | 30,421,000 |
16 | remainder_Expenses | 873,000 |
17 | remainder_Revenues | 8,386,000 |
18 | remainder_NetIncome | 1,254,000 |
19 | remainder_ComprehensiveNetIncome | -3,000 |
yvar | yval | |
---|---|---|
0 | Assets | 66,147,000 |
1 | Liabilities | 14,803,000 |
2 | Expenses | 42,343,000 |
3 | Revenues | 8,386,000 |
4 | StockholdersEquity | 51,344,000 |
5 | NetIncome | -32,703,000 |
6 | ComprehensiveNetIncome | -32,706,000 |
7 | BaseVar | 75,045,690 |
8 | EconomicCapitalRatio | 1.07 |